PriceTargets.com logo

Hamilton Thorne - HTL Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$2.40
  • Forecasted Upside: 65.52%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
C$1.45 As of 09/7/2023 12:59 AM ET
▲ +0.06 (4.32%)

This chart shows the closing price for HTL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Hamilton Thorne Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HTL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HTL

Analyst Price Target is C$2.40
▲ +65.52% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Hamilton Thorne in the last 3 months. The average price target is C$2.40, with a high forecast of C$2.75 and a low forecast of C$2.20. The average price target represents a 65.52% upside from the last price of C$1.45.

This chart shows the closing price for HTL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 3 contributing investment analysts is to buy stock in Hamilton Thorne. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2023Stifel NicolausLower TargetBuyC$3.00 ➝ C$2.75
11/14/2023Canaccord Genuity GroupLower TargetBuyC$2.25 ➝ C$2.20
10/11/2023Pi FinancialBoost TargetBuyC$2.15 ➝ C$2.25
3/22/2022Colliers SecuritiesReiterated RatingBuy
11/22/2021Echelon Wealth PartnersReiterated RatingBuy
7/19/2021CormarkBoost TargetC$2.10 ➝ C$2.25
7/16/2021Acumen CapitalBoost TargetC$2.15 ➝ C$2.40
5/26/2021Acumen CapitalBoost TargetC$2.00 ➝ C$2.15
5/26/2021Pi FinancialBoost TargetC$2.15 ➝ C$2.75
4/9/2021Pi FinancialBoost TargetC$1.80 ➝ C$2.15
4/9/2021Colliers SecuritiesBoost TargetC$1.50 ➝ C$1.60
2/2/2021Colliers SecuritiesReiterated RatingBuyC$1.93
11/20/2020Pi FinancialBoost TargetBuyC$1.70 ➝ C$1.80
8/25/2020CormarkBoost TargetC$1.40 ➝ C$1.70
8/21/2020Bloom BurtonReiterated RatingBuy
8/20/2020Pi FinancialSet TargetBuyC$1.60
6/12/2020Pi FinancialSet TargetBuyC$1.45
6/9/2020Eight CapitalSet TargetBuyC$1.80
6/2/2020Pi FinancialSet TargetBuyC$1.45
5/27/2020Pi FinancialReiterated RatingBuyC$1.45
4/29/2019Beacon SecuritiesReiterated RatingBuy
(Data available from 4/25/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
9/28/2023
  • 1 very positive mentions
  • 6 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
11/27/2023
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/27/2023
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 0 very positive mentions
  • 14 positive mentions
  • 4 negative mentions
  • 2 very negative mentions
Mentions as of
2/25/2024
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 3 very negative mentions
Mentions as of
3/26/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Hamilton Thorne logo
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, it manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as acts as a value-added reseller of a range of capital equipment and consumables. It sells its products and services through a direct sales force in the United States, Germany, France, Australia, Denmark, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.
Read More

Today's Range

Now: C$1.45
Low: C$1.42
High: C$1.45

50 Day Range

MA: C$1.45
Low: C$1.45
High: C$1.45

52 Week Range

Now: C$1.45
Low: C$1.25
High: C$1.73

Volume

25,700 shs

Average Volume

35,118 shs

Market Capitalization

C$212.89 million

P/E Ratio

48.33

Dividend Yield

N/A

Beta

0.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Hamilton Thorne?

The following Wall Street analysts have issued reports on Hamilton Thorne in the last twelve months: Canaccord Genuity Group Inc., Pi Financial, and Stifel Nicolaus.
View the latest analyst ratings for HTL.

What is the current price target for Hamilton Thorne?

3 Wall Street analysts have set twelve-month price targets for Hamilton Thorne in the last year. Their average twelve-month price target is C$2.40, suggesting a possible upside of 65.5%. Stifel Nicolaus has the highest price target set, predicting HTL will reach C$2.75 in the next twelve months. Canaccord Genuity Group Inc. has the lowest price target set, forecasting a price of C$2.20 for Hamilton Thorne in the next year.
View the latest price targets for HTL.

What is the current consensus analyst rating for Hamilton Thorne?

Hamilton Thorne currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HTL will outperform the market and that investors should add to their positions of Hamilton Thorne.
View the latest ratings for HTL.

What other companies compete with Hamilton Thorne?

Other companies that are similar to Hamilton Thorne include Quipt Home Medical, Protech Home Medical, Viemed Healthcare, RIV Capital and Cipher Pharmaceuticals. Learn More about companies similar to Hamilton Thorne.

How do I contact Hamilton Thorne's investor relations team?

Hamilton Thorne's physical mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company's listed phone number is +1-978-9212050. The official website for Hamilton Thorne is www.hamiltonthorne.com. Learn More about contacing Hamilton Thorne investor relations.